Company Number: 14323290

Analysis Date: 2025-07-20 14:29 UTC

Financial Health Score:
Grade: D (Dormant Status with Minimal Financial Activity)
Explanation: OPTERGO LTD is classified as a dormant company with virtually no financial transactions or operational activity since incorporation. The net assets and shareholders’ funds remain minimal and unchanged at £100, representing the original issued share capital. This indicates a lack of active business operations or revenue generation, which severely limits meaningful financial analysis and suggests a very early or inactive stage of business development.

---

Key Vital Signs

Metric	Value (£)	Interpretation
Net Assets	100	Very low asset base, reflecting only share capital
Shareholders’ Funds	100	Equity limited to issued share capital
Account Category	Dormant	No significant financial transactions during the year
Filing Status	Up to date	No overdue filings, compliant with Companies House
Business Activity (SIC)	32500	Manufacture of medical and dental instruments & supplies (planned activity)
Operating History	~2 years	Incorporated in Aug 2022, but no trading activity reported

Interpretation of Vital Signs:

• Dormant status indicates the company has not traded or conducted financial transactions beyond share capital contributions.
• Minimal net assets show no accumulation of profits, no retained earnings, and no operational assets, akin to a patient with no active physiological functions—it is essentially in a state of hibernation.
• Compliance with filing deadlines is a positive sign, reflecting good administrative health despite inactivity.

---

Symptoms Analysis

• The company’s balance sheet is static, showing no growth or change in financial position over the last three reported years.
• Lack of income, expenses, or liabilities reveals no active business operations, sales, or investments.
• No cash flow activity means no operational cash inflows or outflows, which limits the company's ability to grow or sustain itself without external capital infusion.
• The industry classification suggests an intended focus on medical/dental manufacturing, but this is not yet reflected in financial activity or asset acquisition.
• The director has been in post since incorporation, but no trading or operational initiatives are evident yet.

This profile resembles a patient who has been in a comatose or dormant state with no vital signs of activity, requiring intervention or stimulation to awaken and begin functioning.

---

Diagnosis

OPTERGO LTD is currently in a dormant financial condition, meaning it is not actively trading or generating revenue. While this status is legally permissible and common for start-ups in incubation or preparation phases, it means the company is not yet self-sustaining or growing. The lack of financial transactions, assets, liabilities, and profits indicates no operational traction. The company is financially stable only in the sense that it has no debts or losses, but it also shows no signs of business vitality or economic progress.

---

Prognosis

If the company remains dormant, it will continue to have minimal financial health with negligible assets and no income. Without operational activity or capital injection, the company risks stagnation and may face challenges in attracting investment or customers later. However, if the directors proceed with business development, product creation, or market engagement per their SIC classification, the company could transition from dormancy to active trading, improving financial health metrics such as revenue, net assets, and cash flow.

---

Recommendations

1. Activate Operations: Begin business activities aligned with the medical and dental instruments manufacturing sector to generate revenue and build assets.
2. Capital Planning: Assess funding requirements to support start-up costs, production equipment, and working capital needs. Consider equity investment or loans if necessary.
3. Financial Monitoring: Once trading commences, implement regular financial reporting and cash flow management to monitor the company’s financial vital signs actively.
4. Strategic Planning: Develop a clear business plan with milestones and financial projections to guide growth and attract investors or partners.
5. Compliance Maintenance: Continue timely filing of accounts and confirmation statements to maintain good standing with regulatory bodies.
6. Seek Expert Advice: Engage with business advisors or industry specialists to accelerate market entry and operational set-up in the medical manufacturing field.

---